Company Filing History:
Years Active: 1985
Title: U James Lewis: Innovator in Insulin-Potentiating Peptides
Introduction
U James Lewis is a notable inventor based in La Jolla, California. He has made significant contributions to the field of diabetes and endocrinology through his innovative research. His work focuses on the development of insulin-potentiating peptides, which have the potential to enhance insulin action in mammals.
Latest Patents
U James Lewis holds a patent for insulin-potentiating peptides, specifically hGH(1-43). This peptide has the formula: H--Phe--Pro--Thr--Ile--Pro--Leu--Ser--Arg--Leu--Phe--Asp--Asn--Ala--Met--Leu--Arg--Ala--His--Arg--Leu--His--Gln--Leu--Ala--Phe--Asp--Thr--Try--Gln--Glu--Phe--Glu--Glu--Ala--Try--Ile--Pro--Lys--Glu--Gln--Lys--Tyr--Ser--OH. This invention has been found to exhibit remarkable insulin-potentiating action, alongside the fragment hGH(17-43). The pharmaceutical compositions derived from this invention include hGH(1-43), hGH(17-43), or biologically active intermediate fragments, which can be administered to promote insulin action.
Career Highlights
U James Lewis is affiliated with the Whittier Institute for Diabetes & Endocrinology. His work at this institute has allowed him to focus on groundbreaking research in the field of diabetes treatment. His innovative approaches have contributed to advancements in the understanding and management of insulin-related conditions.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
U James Lewis is a prominent inventor whose work on insulin-potentiating peptides has the potential to significantly impact diabetes treatment. His contributions to the field are noteworthy and continue to inspire further research and innovation.